ID   APRIO_HUMAN             Reviewed;          73 AA.
AC   F7VJQ1;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   08-MAY-2019, entry version 38.
DE   RecName: Full=Alternative prion protein;
DE   AltName: Full=AltPrP;
GN   Name=PRNP; Synonyms=ALTPRP, PRIP, PRP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2]
RP   IDENTIFICATION, SUBCELLULAR LOCATION, INDUCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21478263; DOI=10.1096/fj.10-173815;
RA   Vanderperre B., Staskevicius A.B., Tremblay G., McCoy M.,
RA   O'Neill M.A., Cashman N.R., Roucou X.;
RT   "An overlapping reading frame in the PRNP gene encodes a novel
RT   polypeptide distinct from the prion protein.";
RL   FASEB J. 25:2373-2386(2011).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:21478263}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:21478263}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=3;
CC       Name=3; Synonyms=AltPrP;
CC         IsoId=F7VJQ1-1; Sequence=Displayed;
CC       Name=1; Synonyms=PrP;
CC         IsoId=P04156-1; Sequence=External;
CC       Name=2; Synonyms=PrP(M8);
CC         IsoId=P04156-2; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Detected in brain homogenate, primary neurons,
CC       and peripheral blood mononuclear cells (at protein level).
CC       {ECO:0000269|PubMed:21478263}.
CC   -!- INDUCTION: Up-regulated by endoplasmic reticulum stress and
CC       proteasomal inhibition. {ECO:0000269|PubMed:21478263}.
CC   -!- MISCELLANEOUS: This protein is produced by a bicistronic gene
CC       which also produces the major prion protein/PRNP from an
CC       overlapping reading frame. {ECO:0000305|PubMed:21478263}.
CC   -!- MISCELLANEOUS: The alternative prion protein/AltPrP and PRNP (AC
CC       P04156) have no apparent direct functional relation since a
CC       mutation that removes the start codon of the AltPrP has no
CC       apparent effect on the biology of PRNP. In mouse and hamster, the
CC       alternative initiation AUG codon is absent and is replaced by a
CC       GUG codon (PubMed:21478263). {ECO:0000305|PubMed:21478263}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133396; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BK007887; DAA34790.1; -; Genomic_DNA.
DR   RefSeq; NP_001258490.1; NM_001271561.2. [F7VJQ1-1]
DR   BioGrid; 111606; 74.
DR   SwissPalm; F7VJQ1; -.
DR   BioMuta; PRNP; -.
DR   PRIDE; F7VJQ1; -.
DR   GeneID; 5621; -.
DR   CTD; 5621; -.
DR   DisGeNET; 5621; -.
DR   GeneCards; PRNP; -.
DR   GeneReviews; PRNP; -.
DR   HGNC; HGNC:9449; PRNP.
DR   MalaCards; PRNP; -.
DR   neXtProt; NX_F7VJQ1; -.
DR   OrthoDB; 1403854at2759; -.
DR   SIGNOR; F7VJQ1; -.
DR   ChiTaRS; PRNP; human.
DR   GeneWiki; PRNP; -.
DR   GenomeRNAi; 5621; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
PE   1: Evidence at protein level;
KW   Alternative initiation; Complete proteome; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     73       Alternative prion protein.
FT                                /FTId=PRO_0000420424.
FT   TRANSMEM     32     52       Helical. {ECO:0000255}.
FT   COMPBIAS     25     64       Trp-rich.
SQ   SEQUENCE   73 AA;  8691 MW;  4360C28341A4CA52 CRC64;
     MEHWGQPIPG AGQPWRQPLP TSGRWWLGAA SWWWLGAASW WWLGAAPWWW LGTASWWWLG
     SRRWHPQSVE QAE
//
ID   PRIO_PANTR              Reviewed;         253 AA.
AC   P61768; P40253;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 1.
DT   08-MAY-2019, entry version 112.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: Full=PrP27-30;
DE   AltName: Full=PrP33-35C;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor;
GN   Name=PRNP; Synonyms=PRP;
OS   Pan troglodytes (Chimpanzee).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Pan.
OX   NCBI_TaxID=9598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7837269; DOI=10.1006/jmbi.1994.0030;
RA   Schaetzl H.M., Da Costa M., Taylor L., Cohen F.E., Prusiner S.B.;
RT   "Prion protein gene variation among primates.";
RL   J. Mol. Biol. 245:362-374(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=7991600; DOI=10.1073/pnas.91.25.12159;
RA   Cervenakova L., Brown P., Goldfarb L.G., Nagle J., Pettrone K.,
RA   Rubenstein R., Dubnick M., Gibbs C.J., Gajdusek D.C.;
RT   "Infectious amyloid precursor gene sequences in primates used for
RT   experimental transmission of human spongiform encephalopathy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:12159-12162(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15620360; DOI=10.1016/j.cell.2004.11.040;
RA   Dorus S., Vallender E.J., Evans P.D., Anderson J.R., Gilbert S.L.,
RA   Mahowald M., Wyckoff G.J., Malcom C.M., Lahn B.T.;
RT   "Accelerated evolution of nervous system genes in the origin of Homo
RT   sapiens.";
RL   Cell 119:1027-1040(2004).
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental
CC       stresses. May play a role in neuronal development and synaptic
CC       plasticity. May be required for neuronal myelin sheath
CC       maintenance. May play a role in iron uptake and iron homeostasis.
CC       Soluble oligomers are toxic to cultured neuroblastoma cells and
CC       induce apoptosis (in vitro). Association with GPC1 (via its
CC       heparan sulfate chains) targets PRNP to lipid rafts. Also provides
CC       Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
CC       degradation of its heparan sulfate side chains (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent
CC       an intermediate stage on the path to fibril formation. Copper
CC       binding may promote oligomerization. Interacts with GRB2, APP,
CC       ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
CC       interacts with MGRN1; this interaction alters MGRN1 subcellular
CC       location and causes lysosomal enlargement. Interacts with
CC       KIAA1191. {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
CC       {ECO:0000250|UniProtKB:P04156}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
CC       association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear
CC       regions, where both proteins undergo internalization. Heparin
CC       displaces PRNP from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby
CC       trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
CC       At low copper concentrations, the sidechains of His residues from
CC       three or four repeats contribute to the binding of a single copper
CC       ion. Alternatively, a copper ion can be bound by interaction with
CC       the sidechain and backbone amide nitrogen of a single His residue.
CC       The observed copper binding stoichiometry suggests that two repeat
CC       regions cooperate to stabilize the binding of a single copper ion.
CC       At higher copper concentrations, each octamer can bind one copper
CC       ion by interactions with the His sidechain and Gly backbone atoms.
CC       A mixture of binding types may occur, especially in the case of
CC       octamer repeat expansion. Copper binding may stabilize the
CC       conformation of this region and may promote oligomerization.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=PrP is found in high quantity in the brain of humans
CC       and animals infected with the degenerative neurological diseases
CC       kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
CC       syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
CC       transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U08296; AAC50085.1; -; Genomic_DNA.
DR   EMBL; U15039; AAA68632.1; -; Genomic_DNA.
DR   EMBL; AY665268; AAV74306.1; -; mRNA.
DR   PIR; I61847; I61847.
DR   RefSeq; NP_001009093.1; NM_001009093.4.
DR   RefSeq; NP_001103676.1; NM_001110206.3.
DR   RefSeq; XP_009434905.1; XM_009436630.2.
DR   RefSeq; XP_009434906.1; XM_009436631.2.
DR   SMR; P61768; -.
DR   STRING; 9598.ENSPTRP00000022659; -.
DR   PaxDb; P61768; -.
DR   Ensembl; ENSPTRT00000080287; ENSPTRP00000075233; ENSPTRG00000046640.
DR   GeneID; 458076; -.
DR   KEGG; ptr:458076; -.
DR   CTD; 5621; -.
DR   VGNC; VGNC:6248; PRNP.
DR   eggNOG; ENOG410IJMM; Eukaryota.
DR   eggNOG; ENOG410YXUU; LUCA.
DR   GeneTree; ENSGT00510000049083; -.
DR   HOGENOM; HOG000232077; -.
DR   InParanoid; P61768; -.
DR   KO; K05634; -.
DR   OMA; HNPGYPH; -.
DR   OrthoDB; 1403854at2759; -.
DR   TreeFam; TF105188; -.
DR   Proteomes; UP000002277; Chromosome 20.
DR   Bgee; ENSPTRG00000013216; Expressed in 6 organ(s), highest expression level in prefrontal cortex.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0001540; F:amyloid-beta binding; IBA:GO_Central.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IBA:GO_Central.
DR   GO; GO:0051087; F:chaperone binding; IBA:GO_Central.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:1903135; F:cupric ion binding; IBA:GO_Central.
DR   GO; GO:1903136; F:cuprous ion binding; IBA:GO_Central.
DR   GO; GO:0005539; F:glycosaminoglycan binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IBA:GO_Central.
DR   GO; GO:0044325; F:ion channel binding; IBA:GO_Central.
DR   GO; GO:0005521; F:lamin binding; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0002020; F:protease binding; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IBA:GO_Central.
DR   GO; GO:0032147; P:activation of protein kinase activity; IBA:GO_Central.
DR   GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IBA:GO_Central.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IBA:GO_Central.
DR   GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IBA:GO_Central.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IBA:GO_Central.
DR   GO; GO:1902951; P:negative regulation of dendritic spine maintenance; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032700; P:negative regulation of interleukin-17 production; IEA:Ensembl.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:1990535; P:neuron projection maintenance; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:1901216; P:positive regulation of neuron death; IBA:GO_Central.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IBA:GO_Central.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IBA:GO_Central.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IBA:GO_Central.
DR   GO; GO:1905664; P:regulation of calcium ion import across plasma membrane; IEA:Ensembl.
DR   GO; GO:1900449; P:regulation of glutamate receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:1902938; P:regulation of intracellular calcium activated chloride channel activity; IEA:Ensembl.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IBA:GO_Central.
DR   GO; GO:0006979; P:response to oxidative stress; IBA:GO_Central.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   2: Evidence at transcript level;
KW   Amyloid; Cell membrane; Complete proteome; Copper; Disulfide bond;
KW   Glycoprotein; Golgi apparatus; GPI-anchor; Lipoprotein; Membrane;
KW   Metal-binding; Prion; Reference proteome; Repeat; Signal; Zinc.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    230       Major prion protein.
FT                                /FTId=PRO_0000025711.
FT   PROPEP      231    253       Removed in mature form. {ECO:0000250}.
FT                                /FTId=PRO_0000025712.
FT   REPEAT       51     59       1.
FT   REPEAT       60     67       2.
FT   REPEAT       68     75       3.
FT   REPEAT       76     83       4.
FT   REPEAT       84     91       5.
FT   REGION       23    230       Interaction with GRB2, ERI3 and SYN1.
FT                                {ECO:0000250|UniProtKB:P04925}.
FT   REGION       51     91       5 X 8 AA tandem repeats of P-H-G-G-G-W-G-
FT                                Q.
FT   METAL        61     61       Copper or zinc 1.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        62     62       Copper or zinc 1; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        63     63       Copper or zinc 1; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        69     69       Copper or zinc 2.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        70     70       Copper or zinc 2; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        71     71       Copper or zinc 2; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        77     77       Copper or zinc 3.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        78     78       Copper or zinc 3; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        79     79       Copper or zinc 3; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        85     85       Copper or zinc 4.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        86     86       Copper or zinc 4; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        87     87       Copper or zinc 4; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   LIPID       230    230       GPI-anchor amidated serine.
FT                                {ECO:0000250|UniProtKB:P04273}.
FT   CARBOHYD    181    181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    197    197       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    179    214       {ECO:0000250|UniProtKB:P04273}.
SQ   SEQUENCE   253 AA;  27633 MW;  CF8F59F040996B74 CRC64;
     MANLGCWMLV LFVATWSDLG LCKKRPKPGG WNTGGSRYPG QGSPGGNRYP PQGGGGWGQP
     HGGGWGQPHG GGWGQPHGGG WGQPHGGGWG QGGGTHSQWN KPSKPKTNMK HMAGAAAAGA
     VVGGLGGYML GSAMSRPIIH FGSDYEDRYY RENMHRYPNQ VYYRPMDQYS SQNNFVHDCV
     NITIKQHTVT TTTKGENFTE TDVKMMERVV EQMCITQYER ESQAYYQRGS SMVLFSSPPV
     ILLISFLIFL IVG
//
ID   SPRN_HUMAN              Reviewed;         151 AA.
AC   Q5BIV9;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 1.
DT   08-MAY-2019, entry version 92.
DE   RecName: Full=Shadow of prion protein;
DE            Short=Protein shadoo;
DE   Flags: Precursor;
GN   Name=SPRN; Synonyms=SHO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=14527721; DOI=10.1016/S0378-1119(03)00707-8;
RA   Premzl M., Sangiorgio L., Strumbo B., Marshall Graves J.A.,
RA   Simonic T., Gready J.E.;
RT   "Shadoo, a new protein highly conserved from fish to mammals and with
RT   similarity to prion protein.";
RL   Gene 314:89-102(2003).
RN   [3]
RP   PHYLOGENY.
RX   PubMed=15342797; DOI=10.1093/molbev/msh245;
RA   Premzl M., Gready J.E., Jermiin L.S., Simonic T.,
RA   Marshall Graves J.A.;
RT   "Evolution of vertebrate genes related to prion and Shadoo proteins-
RT   Clues from comparative genomic analysis.";
RL   Mol. Biol. Evol. 21:2210-2231(2004).
RN   [4]
RP   PHYLOGENY.
RX   PubMed=17199895; DOI=10.1186/1471-2164-8-1;
RA   Premzl M., Gamulin V.;
RT   "Comparative genomic analysis of prion genes.";
RL   BMC Genomics 8:1-1(2007).
CC   -!- FUNCTION: Prion-like protein that has PrP(C)-like neuroprotective
CC       activity. May act as a modulator for the biological actions of
CC       normal and abnormal PrP (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor,
CC       GPI-anchor {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in brain. In brain, it is
CC       expressed in hippocampus. {ECO:0000269|PubMed:14527721}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: 'Shadoo' means 'shadow' in Japanese.
CC   -!- SIMILARITY: Belongs to the SPRN family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BC040198; AAH40198.1; -; mRNA.
DR   EMBL; BN000518; CAG34288.1; -; Genomic_DNA.
DR   CCDS; CCDS53589.1; -.
DR   RefSeq; NP_001012526.2; NM_001012508.3.
DR   SMR; Q5BIV9; -.
DR   IntAct; Q5BIV9; 1.
DR   STRING; 9606.ENSP00000433712; -.
DR   TCDB; 1.C.48.1.5; the prion peptide (prp) family.
DR   iPTMnet; Q5BIV9; -.
DR   PhosphoSitePlus; Q5BIV9; -.
DR   BioMuta; SPRN; -.
DR   DMDM; 74722519; -.
DR   jPOST; Q5BIV9; -.
DR   PaxDb; Q5BIV9; -.
DR   PeptideAtlas; Q5BIV9; -.
DR   PRIDE; Q5BIV9; -.
DR   ProteomicsDB; 62673; -.
DR   Ensembl; ENST00000414069; ENSP00000433712; ENSG00000203772.
DR   GeneID; 503542; -.
DR   KEGG; hsa:503542; -.
DR   UCSC; uc001lnf.5; human.
DR   CTD; 503542; -.
DR   DisGeNET; 503542; -.
DR   GeneCards; SPRN; -.
DR   HGNC; HGNC:16871; SPRN.
DR   MIM; 610447; gene.
DR   neXtProt; NX_Q5BIV9; -.
DR   OpenTargets; ENSG00000203772; -.
DR   PharmGKB; PA142670876; -.
DR   eggNOG; ENOG410JEZN; Eukaryota.
DR   eggNOG; ENOG41114XD; LUCA.
DR   GeneTree; ENSGT00730000111694; -.
DR   InParanoid; Q5BIV9; -.
DR   OMA; YRAWTSG; -.
DR   PhylomeDB; Q5BIV9; -.
DR   TreeFam; TF330766; -.
DR   Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   GenomeRNAi; 503542; -.
DR   PRO; PR:Q5BIV9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000203772; Expressed in 118 organ(s), highest expression level in right frontal lobe.
DR   Genevisible; Q5BIV9; HS.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   InterPro; IPR029238; Shadoo.
DR   PANTHER; PTHR28552; PTHR28552; 1.
DR   Pfam; PF14999; Shadoo; 1.
PE   2: Evidence at transcript level;
KW   Amyloid; Cell membrane; Complete proteome; Glycoprotein; GPI-anchor;
KW   Lipoprotein; Membrane; Polymorphism; Prion; Reference proteome;
KW   Signal.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    126       Shadow of prion protein.
FT                                /FTId=PRO_5000096015.
FT   PROPEP      127    151       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000320166.
FT   COMPBIAS      4     93       Ala-rich.
FT   LIPID       126    126       GPI-anchor amidated glycine.
FT                                {ECO:0000255}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       7      7       T -> M (in dbSNP:rs2492666).
FT                                /FTId=VAR_039152.
SQ   SEQUENCE   151 AA;  14522 MW;  AE545DB777F9110E CRC64;
     MNWAPATCWA LLLAAAFLCD SGAAKGGRGG ARGSARGGVR GGARGASRVR VRPAQRYGAP
     GSSLRVAAAG AAAGAAAGAA AGLAAGSGWR RAAGPGERGL EDEEDGVPGG NGTGPGIYSY
     RAWTSGAGPT RGPRLCLVLG GALGALGLLR P
//
ID   APRIO_SHEEP             Reviewed;          64 AA.
AC   F7VJQ3;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 1.
DT   07-JAN-2015, entry version 8.
DE   RecName: Full=Alternative prion protein;
DE   AltName: Full=AltPrP;
OS   Ovis aries (Sheep).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Caprinae; Ovis.
OX   NCBI_TaxID=9940;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Roucou X.;
RL   Submitted (SEP-2012) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=21478263; DOI=10.1096/fj.10-173815;
RA   Vanderperre B., Staskevicius A.B., Tremblay G., McCoy M.,
RA   O'Neill M.A., Cashman N.R., Roucou X.;
RT   "An overlapping reading frame in the PRNP gene encodes a novel
RT   polypeptide distinct from the prion protein.";
RL   FASEB J. 25:2373-2386(2011).
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Single-pass membrane protein {ECO:0000250}.
CC   -!- MISCELLANEOUS: This protein is produced by a bicistronic gene
CC       which also produces the major prion protein/PRNP from an
CC       overlapping reading frame.
CC   -!- MISCELLANEOUS: The alternative prion protein and PRNP (AC P23907)
CC       have no apparent direct functional relation since a mutation that
CC       removes the start codon of the AltPrP has no apparent effect on
CC       the biology of PRNP (By similarity). In mouse and hamster, the
CC       alternative initiation AUG codon is absent and is replaced by a
CC       GUG codon. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; HE993880; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BK007889; DAA34792.1; -; Genomic_DNA.
DR   Proteomes; UP000002356; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
PE   3: Inferred from homology;
KW   Complete proteome; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     64       Alternative prion protein.
FT                                /FTId=PRO_0000420425.
FT   TRANSMEM     40     58       Helical. {ECO:0000255}.
FT   COMPBIAS     26     64       Trp-rich.
SQ   SEQUENCE   64 AA;  7619 MW;  00B917A13D0DA1E4 CRC64;
     MEHWGEPIPG TGQSWRQPLS TSGRGWLGSA PWRWLGPTSW RWLGSAPWWW LGTATWWWRL
     GSRW
//
ID   PRIO_OVIMU              Reviewed;         256 AA.
AC   Q7JK02;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   08-MAY-2019, entry version 70.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor;
GN   Name=PRNP; Synonyms=PRP;
OS   Ovis aries musimon (Mouflon).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Caprinae; Ovis.
OX   NCBI_TaxID=9938;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11805443; DOI=10.1159/000050072;
RA   Seo S.W., Hara K., Kubosaki A., Nasu Y., Nishimura T., Saeki K.,
RA   Matsumoto Y., Endo H., Onodera T.;
RT   "Comparative analysis of the prion protein open reading frame
RT   nucleotide sequences of two wild ruminants, the moufflon and golden
RT   takin.";
RL   Intervirology 44:359-363(2001).
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental
CC       stresses. May play a role in neuronal development and synaptic
CC       plasticity. May be required for neuronal myelin sheath
CC       maintenance. May play a role in iron uptake and iron homeostasis.
CC       Soluble oligomers are toxic to cultured neuroblastoma cells and
CC       induce apoptosis (in vitro). Association with GPC1 (via its
CC       heparan sulfate chains) targets PRNP to lipid rafts. Also provides
CC       Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
CC       degradation of its heparan sulfate side chains (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent
CC       an intermediate stage on the path to fibril formation. Copper
CC       binding may promote oligomerization. Interacts with GRB2, APP,
CC       ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
CC       interacts with MGRN1; this interaction alters MGRN1 subcellular
CC       location and causes lysosomal enlargement. Interacts with
CC       KIAA1191. {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
CC       {ECO:0000250|UniProtKB:P04156}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
CC       association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear
CC       regions, where both proteins undergo internalization. Heparin
CC       displaces PRNP from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby
CC       trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
CC       At low copper concentrations, the sidechains of His residues from
CC       three or four repeats contribute to the binding of a single copper
CC       ion. Alternatively, a copper ion can be bound by interaction with
CC       the sidechain and backbone amide nitrogen of a single His residue.
CC       The observed copper binding stoichiometry suggests that two repeat
CC       regions cooperate to stabilize the binding of a single copper ion.
CC       At higher copper concentrations, each octamer can bind one copper
CC       ion by interactions with the His sidechain and Gly backbone atoms.
CC       A mixture of binding types may occur, especially in the case of
CC       octamer repeat expansion. Copper binding may stabilize the
CC       conformation of this region and may promote oligomerization.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=Found in high quantity in the brain of humans and
CC       animals infected with degenerative neurological diseases such as
CC       kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
CC       syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
CC       transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB060288; BAB69955.1; -; mRNA.
DR   EMBL; AB060289; BAB69956.1; -; mRNA.
DR   SMR; Q7JK02; -.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   2: Evidence at transcript level;
KW   Amyloid; Cell membrane; Copper; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; GPI-anchor; Lipoprotein; Membrane; Metal-binding;
KW   Prion; Repeat; Signal; Zinc.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    233       Major prion protein.
FT                                /FTId=PRO_0000025709.
FT   PROPEP      234    256       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000025710.
FT   REPEAT       54     62       1.
FT   REPEAT       63     70       2.
FT   REPEAT       71     78       3.
FT   REPEAT       79     86       4.
FT   REPEAT       87     95       5.
FT   REGION       25    233       Interaction with GRB2, ERI3 and SYN1.
FT                                {ECO:0000250|UniProtKB:P04925}.
FT   REGION       54     95       5 X 8 AA tandem repeats of P-H-G-G-G-W-G-
FT                                Q.
FT   METAL        64     64       Copper or zinc 1.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        65     65       Copper or zinc 1; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        66     66       Copper or zinc 1; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        72     72       Copper or zinc 2.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        73     73       Copper or zinc 2; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        74     74       Copper or zinc 2; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        80     80       Copper or zinc 3.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        81     81       Copper or zinc 3; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        82     82       Copper or zinc 3; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        88     88       Copper or zinc 4.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        90     90       Copper or zinc 4; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        91     91       Copper or zinc 4; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   LIPID       233    233       GPI-anchor amidated alanine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   DISULFID    182    217       {ECO:0000250|UniProtKB:P04273}.
SQ   SEQUENCE   256 AA;  27887 MW;  BFC8E95F6FD99746 CRC64;
     MVKSHIGSWI LVLFVAMWSD VGLCKKRPKP GGGWNTGGSR YPGQGSPGGN RYPPQGGGGW
     GQPHGGGWGQ PHGGGWGQPH GGGWGQPHGG GGWGQGGSHS QWNKPSKPKT NMKHVAGAAA
     AGAVVGGLGG YMLGSAMSRP LIHFGNDYED RYYRENMYRY PNQVYYRPVD QYSNQNNFVH
     DCVNITVKQH TVTTTTKGEN FTETDIKIME RVVEQMCITQ YQRESQAYYQ RGASVILFSS
     PPVILLISFL IFLIVG
//
ID   PRIO_OVIMO              Reviewed;         256 AA.
AC   Q7JIY2;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   08-MAY-2019, entry version 67.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor;
GN   Name=PRNP; Synonyms=PRP;
OS   Ovibos moschatus (Muskox).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Caprinae; Ovibos.
OX   NCBI_TaxID=37176;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10373359; DOI=10.1006/jmbi.1999.2831;
RA   Wopfner F., Weidenhofer G., Schneider R., von Brunn A., Gilch S.,
RA   Schwarz T.F., Werner T., Schatzl H.M.;
RT   "Analysis of 27 mammalian and 9 avian PrPs reveals high conservation
RT   of flexible regions of the prion protein.";
RL   J. Mol. Biol. 289:1163-1178(1999).
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental
CC       stresses. May play a role in neuronal development and synaptic
CC       plasticity. May be required for neuronal myelin sheath
CC       maintenance. May play a role in iron uptake and iron homeostasis.
CC       Soluble oligomers are toxic to cultured neuroblastoma cells and
CC       induce apoptosis (in vitro). Association with GPC1 (via its
CC       heparan sulfate chains) targets PRNP to lipid rafts. Also provides
CC       Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
CC       degradation of its heparan sulfate side chains (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent
CC       an intermediate stage on the path to fibril formation. Copper
CC       binding may promote oligomerization. Interacts with GRB2, APP,
CC       ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
CC       interacts with MGRN1; this interaction alters MGRN1 subcellular
CC       location and causes lysosomal enlargement. Interacts with
CC       KIAA1191. {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
CC       {ECO:0000250|UniProtKB:P04156}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
CC       association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear
CC       regions, where both proteins undergo internalization. Heparin
CC       displaces PRNP from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby
CC       trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
CC       At low copper concentrations, the sidechains of His residues from
CC       three or four repeats contribute to the binding of a single copper
CC       ion. Alternatively, a copper ion can be bound by interaction with
CC       the sidechain and backbone amide nitrogen of a single His residue.
CC       The observed copper binding stoichiometry suggests that two repeat
CC       regions cooperate to stabilize the binding of a single copper ion.
CC       At higher copper concentrations, each octamer can bind one copper
CC       ion by interactions with the His sidechain and Gly backbone atoms.
CC       A mixture of binding types may occur, especially in the case of
CC       octamer repeat expansion. Copper binding may stabilize the
CC       conformation of this region and may promote oligomerization.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=Found in high quantity in the brain of humans and
CC       animals infected with degenerative neurological diseases such as
CC       kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
CC       syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
CC       transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF117320; AAD19991.1; -; Genomic_DNA.
DR   SMR; Q7JIY2; -.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   3: Inferred from homology;
KW   Amyloid; Cell membrane; Copper; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; GPI-anchor; Lipoprotein; Membrane; Metal-binding;
KW   Prion; Repeat; Signal; Zinc.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    233       Major prion protein.
FT                                /FTId=PRO_0000025707.
FT   PROPEP      234    256       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000025708.
FT   REPEAT       54     62       1.
FT   REPEAT       63     70       2.
FT   REPEAT       71     78       3.
FT   REPEAT       79     86       4.
FT   REPEAT       87     95       5.
FT   REGION       25    233       Interaction with GRB2, ERI3 and SYN1.
FT                                {ECO:0000250|UniProtKB:P04925}.
FT   REGION       54     95       5 X 8 AA tandem repeats of P-H-G-G-G-W-G-
FT                                Q.
FT   METAL        64     64       Copper or zinc 1.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        65     65       Copper or zinc 1; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        66     66       Copper or zinc 1; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        72     72       Copper or zinc 2.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        73     73       Copper or zinc 2; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        74     74       Copper or zinc 2; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        80     80       Copper or zinc 3.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        81     81       Copper or zinc 3; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        82     82       Copper or zinc 3; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        88     88       Copper or zinc 4.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        90     90       Copper or zinc 4; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        91     91       Copper or zinc 4; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   LIPID       233    233       GPI-anchor amidated alanine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   DISULFID    182    217       {ECO:0000250|UniProtKB:P04273}.
SQ   SEQUENCE   256 AA;  27887 MW;  BFC8E95F6FD99746 CRC64;
     MVKSHIGSWI LVLFVAMWSD VGLCKKRPKP GGGWNTGGSR YPGQGSPGGN RYPPQGGGGW
     GQPHGGGWGQ PHGGGWGQPH GGGWGQPHGG GGWGQGGSHS QWNKPSKPKT NMKHVAGAAA
     AGAVVGGLGG YMLGSAMSRP LIHFGNDYED RYYRENMYRY PNQVYYRPVD QYSNQNNFVH
     DCVNITVKQH TVTTTTKGEN FTETDIKIME RVVEQMCITQ YQRESQAYYQ RGASVILFSS
     PPVILLISFL IFLIVG
//
ID   PRIO_CHICK              Reviewed;         273 AA.
AC   P27177;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 2.
DT   08-MAY-2019, entry version 154.
DE   RecName: Full=Major prion protein homolog;
DE   AltName: Full=65-21 protein;
DE   AltName: Full=Acetylcholine receptor-inducing activity;
DE            Short=ARIA;
DE   AltName: Full=PR-LP;
DE   Flags: Precursor;
GN   Name=PRNP; Synonyms=PRN-P;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1409608; DOI=10.1073/pnas.89.19.9097;
RA   Gabriel J.M., Oesch B., Kretzschmar H., Scott M., Prusiner S.B.;
RT   "Molecular cloning of a candidate chicken prion protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:9097-9101(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 25-51.
RC   TISSUE=Brain;
RX   PubMed=1715573; DOI=10.1073/pnas.88.17.7664;
RA   Harris D.A., Falls D.L., Johnson F.A., Fischbach G.D.;
RT   "A prion-like protein from chicken brain copurifies with an
RT   acetylcholine receptor-inducing activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7664-7668(1991).
RN   [3]
RP   REVIEW.
RX   PubMed=2132829;
RA   Falls D.L., Harris D.A., Johnson F.A., Morgan M.M., Corfas G.,
RA   Fischbach G.D.;
RT   "Mr 42,000 ARIA: a protein that may regulate the accumulation of
RT   acetylcholine receptors at developing chick neuromuscular junctions.";
RL   Cold Spring Harb. Symp. Quant. Biol. 55:397-406(1990).
RN   [4]
RP   STRUCTURE BY NMR OF 134-248.
RX   PubMed=15647366; DOI=10.1073/pnas.0408939102;
RA   Calzolai L., Lysek D.A., Perez D.R., Guentert P., Wuethrich K.;
RT   "Prion protein NMR structures of chickens, turtles, and frogs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:651-655(2005).
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental
CC       stresses. May play a role in neuronal development and synaptic
CC       plasticity. May be required for neuronal myelin sheath
CC       maintenance. May play a role in iron uptake and iron homeostasis.
CC       Soluble oligomers are toxic to cultured neuroblastoma cells and
CC       induce apoptosis (in vitro). Association with GPC1 (via its
CC       heparan sulfate chains) targets PRNP to lipid rafts. Also provides
CC       Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
CC       degradation of its heparan sulfate side chains (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent
CC       an intermediate stage on the path to fibril formation. Copper
CC       binding may promote oligomerization.
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.
CC   -!- TISSUE SPECIFICITY: Spinal cord and brain.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; M95404; AAC28970.1; -; Genomic_DNA.
DR   EMBL; M61145; AAA49041.1; -; mRNA.
DR   PIR; A37372; A37372.
DR   PIR; A41280; UJCH.
DR   PIR; A46280; A46280.
DR   RefSeq; NP_990796.2; NM_205465.2.
DR   RefSeq; XP_015152786.1; XM_015297300.1.
DR   PDB; 1U3M; NMR; -; A=134-248.
DR   PDBsum; 1U3M; -.
DR   SMR; P27177; -.
DR   STRING; 9031.ENSGALP00000040285; -.
DR   PaxDb; P27177; -.
DR   PRIDE; P27177; -.
DR   Ensembl; ENSGALT00000000277; ENSGALP00000040285; ENSGALG00000000209.
DR   GeneID; 396452; -.
DR   KEGG; gga:396452; -.
DR   CTD; 5621; -.
DR   eggNOG; ENOG410IJMM; Eukaryota.
DR   eggNOG; ENOG410YXUU; LUCA.
DR   GeneTree; ENSGT00510000049083; -.
DR   HOGENOM; HOG000232077; -.
DR   InParanoid; P27177; -.
DR   KO; K05634; -.
DR   OMA; HNPGYPH; -.
DR   OrthoDB; 1403854at2759; -.
DR   PhylomeDB; P27177; -.
DR   TreeFam; TF105188; -.
DR   EvolutionaryTrace; P27177; -.
DR   PRO; PR:P27177; -.
DR   Proteomes; UP000000539; Chromosome 22.
DR   Bgee; ENSGALG00000000209; Expressed in 11 organ(s), highest expression level in brain.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005604; C:basement membrane; IDA:AgBase.
DR   GO; GO:0005623; C:cell; IDA:AgBase.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043083; C:synaptic cleft; IDA:AgBase.
DR   GO; GO:0001540; F:amyloid-beta binding; IBA:GO_Central.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IBA:GO_Central.
DR   GO; GO:0051087; F:chaperone binding; IBA:GO_Central.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:1903135; F:cupric ion binding; IBA:GO_Central.
DR   GO; GO:1903136; F:cuprous ion binding; IBA:GO_Central.
DR   GO; GO:0005539; F:glycosaminoglycan binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IBA:GO_Central.
DR   GO; GO:0044325; F:ion channel binding; IBA:GO_Central.
DR   GO; GO:0005521; F:lamin binding; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0002020; F:protease binding; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IBA:GO_Central.
DR   GO; GO:0032147; P:activation of protein kinase activity; IBA:GO_Central.
DR   GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IBA:GO_Central.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IBA:GO_Central.
DR   GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IBA:GO_Central.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IBA:GO_Central.
DR   GO; GO:1902951; P:negative regulation of dendritic spine maintenance; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032700; P:negative regulation of interleukin-17 production; IEA:Ensembl.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:1990535; P:neuron projection maintenance; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:AgBase.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:1901216; P:positive regulation of neuron death; IBA:GO_Central.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:AgBase.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IBA:GO_Central.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0010870; P:positive regulation of receptor biosynthetic process; IDA:AgBase.
DR   GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IBA:GO_Central.
DR   GO; GO:0098737; P:protein insertion into plasma membrane; IDA:AgBase.
DR   GO; GO:1905664; P:regulation of calcium ion import across plasma membrane; IEA:Ensembl.
DR   GO; GO:1900449; P:regulation of glutamate receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:1902938; P:regulation of intracellular calcium activated chloride channel activity; IEA:Ensembl.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IBA:GO_Central.
DR   GO; GO:0006979; P:response to oxidative stress; IBA:GO_Central.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amyloid; Cell membrane; Complete proteome; Copper;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Lipoprotein; Membrane; Metal-binding; Prion; Reference proteome;
KW   Repeat; Signal.
FT   SIGNAL        1     24       {ECO:0000269|PubMed:1715573}.
FT   CHAIN        25    248       Major prion protein homolog.
FT                                /FTId=PRO_0000025741.
FT   PROPEP      249    273       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000025742.
FT   REPEAT       42     47       1.
FT   REPEAT       48     53       2.
FT   REPEAT       54     59       3.
FT   REPEAT       60     65       4.
FT   REPEAT       66     71       5.
FT   REPEAT       72     77       6.
FT   REPEAT       78     83       7.
FT   REPEAT       84     89       8.
FT   REGION       42     89       8 X 6 AA tandem repeats of [HR]-[NQ]-P-G-
FT                                Y-P.
FT   METAL        66     66       Copper or zinc 1.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        72     72       Copper or zinc 2.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        78     78       Copper or zinc 3.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        90     90       Copper or zinc 4.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        93     93       Copper or zinc 4; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   LIPID       248    248       GPI-anchor amidated serine.
FT                                {ECO:0000250|UniProtKB:P04273}.
FT   CARBOHYD    194    194       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    209    209       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    218    218       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    192    237
FT   CONFLICT     78     83       Missing (in Ref. 2; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    156    156       S -> R (in Ref. 2; AAA49041).
FT                                {ECO:0000305}.
FT   STRAND      134    136       {ECO:0000244|PDB:1U3M}.
FT   HELIX       157    167       {ECO:0000244|PDB:1U3M}.
FT   HELIX       185    200       {ECO:0000244|PDB:1U3M}.
FT   HELIX       219    246       {ECO:0000244|PDB:1U3M}.
SQ   SEQUENCE   273 AA;  29909 MW;  32D700918E787DD2 CRC64;
     MARLLTTCCL LALLLAACTD VALSKKGKGK PSGGGWGAGS HRQPSYPRQP GYPHNPGYPH
     NPGYPHNPGY PHNPGYPHNP GYPQNPGYPH NPGYPGWGQG YNPSSGGSYH NQKPWKPPKT
     NFKHVAGAAA AGAVVGGLGG YAMGRVMSGM NYHFDSPDEY RWWSENSARY PNRVYYRDYS
     SPVPQDVFVA DCFNITVTEY SIGPAAKKNT SEAVAAANQT EVEMENKVVT KVIREMCVQQ
     YREYRLASGI QLHPADTWLA VLLLLLTTLF AMH
//
ID   SPRN_RAT                Reviewed;         147 AA.
AC   Q5BIV7;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 1.
DT   08-MAY-2019, entry version 71.
DE   RecName: Full=Shadow of prion protein;
DE            Short=Protein shadoo;
DE   Flags: Precursor;
GN   Name=Sprn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T.,
RA   Smith D., Lee H.-M., Gustafson E., Cahill P., Kana A.,
RA   Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M.,
RA   Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K.,
RA   Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S.,
RA   Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J.,
RA   Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y.,
RA   Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A.,
RA   Ren Y., Song X.-Z., Li B., Liu Y., Qin X., Cawley S., Cooney A.J.,
RA   D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R.,
RA   Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A.,
RA   Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E.,
RA   Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E.,
RA   Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D.,
RA   Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M.,
RA   Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O.,
RA   Poliakov A., Huebner N., Ganten D., Goesele C., Hummel O.,
RA   Kreitler T., Lee Y.-A., Monti J., Schulz H., Zimdahl H.,
RA   Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S.,
RA   Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J.,
RA   Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E.,
RA   Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F.,
RA   Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K.,
RA   Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S.,
RA   Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M.,
RA   Clarke L., Curwen V., Durbin R.M., Eyras E., Searle S.M., Cooper G.M.,
RA   Batzoglou S., Brudno M., Sidow A., Stone E.A., Payseur B.A.,
RA   Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S.,
RA   Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G.,
RA   Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H.,
RA   Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R.,
RA   Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M.,
RA   Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H.,
RA   Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S.,
RA   Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into
RT   mammalian evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=14527721; DOI=10.1016/S0378-1119(03)00707-8;
RA   Premzl M., Sangiorgio L., Strumbo B., Marshall Graves J.A.,
RA   Simonic T., Gready J.E.;
RT   "Shadoo, a new protein highly conserved from fish to mammals and with
RT   similarity to prion protein.";
RL   Gene 314:89-102(2003).
CC   -!- FUNCTION: Prion-like protein that has PrP(C)-like neuroprotective
CC       activity. May act as a modulator for the biological actions of
CC       normal and abnormal PrP (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor,
CC       GPI-anchor {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Almost exclusively expressed in brain, with
CC       weak expression in lung and stomach.
CC       {ECO:0000269|PubMed:14527721}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SPRN family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AABR03003407; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BN000520; CAG34290.1; -; Genomic_DNA.
DR   RefSeq; NP_001027015.1; NM_001031845.1.
DR   RefSeq; XP_006230635.1; XM_006230573.3.
DR   SMR; Q5BIV7; -.
DR   STRING; 10116.ENSRNOP00000025609; -.
DR   PaxDb; Q5BIV7; -.
DR   PRIDE; Q5BIV7; -.
DR   Ensembl; ENSRNOT00000025609; ENSRNOP00000025609; ENSRNOG00000018927.
DR   GeneID; 541462; -.
DR   KEGG; rno:541462; -.
DR   UCSC; RGD:1561845; rat.
DR   CTD; 503542; -.
DR   RGD; 1561845; Sprn.
DR   eggNOG; ENOG410JEZN; Eukaryota.
DR   eggNOG; ENOG41114XD; LUCA.
DR   GeneTree; ENSGT00730000111694; -.
DR   HOGENOM; HOG000232075; -.
DR   InParanoid; Q5BIV7; -.
DR   OMA; YRAWTSG; -.
DR   OrthoDB; 1621494at2759; -.
DR   TreeFam; TF330766; -.
DR   Reactome; R-RNO-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   PRO; PR:Q5BIV7; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000018927; Expressed in 8 organ(s), highest expression level in brain.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   InterPro; IPR029238; Shadoo.
DR   PANTHER; PTHR28552; PTHR28552; 1.
DR   Pfam; PF14999; Shadoo; 1.
PE   2: Evidence at transcript level;
KW   Amyloid; Cell membrane; Complete proteome; Glycoprotein; GPI-anchor;
KW   Lipoprotein; Membrane; Prion; Reference proteome; Signal.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    122       Shadow of prion protein.
FT                                /FTId=PRO_5000096017.
FT   PROPEP      123    147       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000320169.
FT   COMPBIAS      5     80       Ala-rich.
FT   LIPID       122    122       GPI-anchor amidated glycine.
FT                                {ECO:0000255}.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   147 AA;  14712 MW;  0B792178D75C65A3 CRC64;
     MNWTTATCWA LLLATAFLCD SCSAKGGRGG ARGSARGVRG GARGASRVRV RPAPRYSSSL
     RVAAAGAAAG AAAGVAAGLA TGSGWRRTSG PGELGLEDDE NGAMGGNGTD RGVYSYWAWT
     SGSGSVHSPR ICLLLSGTLG ALELLRP
//
ID   PRIO_LOPAT              Reviewed;         238 AA.
AC   P67990; Q95145; Q95200;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   08-MAY-2019, entry version 68.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: Full=PrP27-30;
DE   AltName: Full=PrP33-35C;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor; Fragment;
GN   Name=PRNP; Synonyms=PRP;
OS   Lophocebus aterrimus (Black crested mangabey) (Cercocebus aterrimus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Cercopithecidae; Cercopithecinae; Lophocebus.
OX   NCBI_TaxID=75566;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   van der Kuyl A.C., Dekker J.T., Goudsmit J.;
RT   "Evidence for an increased substitution rate of the hominoid prion
RT   protein gene during the period of brain expansion.";
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental
CC       stresses. May play a role in neuronal development and synaptic
CC       plasticity. May be required for neuronal myelin sheath
CC       maintenance. May play a role in iron uptake and iron homeostasis.
CC       Soluble oligomers are toxic to cultured neuroblastoma cells and
CC       induce apoptosis (in vitro). Association with GPC1 (via its
CC       heparan sulfate chains) targets PRNP to lipid rafts. Also provides
CC       Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
CC       degradation of its heparan sulfate side chains (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent
CC       an intermediate stage on the path to fibril formation. Copper
CC       binding may promote oligomerization. Interacts with GRB2, APP,
CC       ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
CC       interacts with MGRN1; this interaction alters MGRN1 subcellular
CC       location and causes lysosomal enlargement. Interacts with
CC       KIAA1191. {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
CC       {ECO:0000250|UniProtKB:P04156}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
CC       association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear
CC       regions, where both proteins undergo internalization. Heparin
CC       displaces PRNP from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby
CC       trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
CC       At low copper concentrations, the sidechains of His residues from
CC       three or four repeats contribute to the binding of a single copper
CC       ion. Alternatively, a copper ion can be bound by interaction with
CC       the sidechain and backbone amide nitrogen of a single His residue.
CC       The observed copper binding stoichiometry suggests that two repeat
CC       regions cooperate to stabilize the binding of a single copper ion.
CC       At higher copper concentrations, each octamer can bind one copper
CC       ion by interactions with the His sidechain and Gly backbone atoms.
CC       A mixture of binding types may occur, especially in the case of
CC       octamer repeat expansion. Copper binding may stabilize the
CC       conformation of this region and may promote oligomerization.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=PrP is found in high quantity in the brain of humans
CC       and animals infected with the degenerative neurological diseases
CC       kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
CC       syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
CC       transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U75384; AAB50623.1; -; Genomic_DNA.
DR   SMR; P67990; -.
DR   PRIDE; P67990; -.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   3: Inferred from homology;
KW   Amyloid; Cell membrane; Copper; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; GPI-anchor; Lipoprotein; Membrane; Metal-binding;
KW   Prion; Repeat; Signal; Zinc.
FT   SIGNAL       <1     15       {ECO:0000250}.
FT   CHAIN        16    215       Major prion protein.
FT                                /FTId=PRO_0000025649.
FT   PROPEP      216    238       Removed in mature form. {ECO:0000250}.
FT                                /FTId=PRO_0000025650.
FT   REPEAT       44     52       1.
FT   REPEAT       53     60       2.
FT   REPEAT       61     68       3.
FT   REPEAT       69     76       4.
FT   REGION       16    215       Interaction with GRB2, ERI3 and SYN1.
FT                                {ECO:0000250|UniProtKB:P04925}.
FT   REGION       44     76       4 X 8 AA tandem repeats of P-H-G-G-G-W-G-
FT                                Q.
FT   METAL        47     47       Copper or zinc 1; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        48     48       Copper or zinc 1; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        54     54       Copper or zinc 2.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        55     55       Copper or zinc 2; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        56     56       Copper or zinc 2; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        62     62       Copper or zinc 3.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        63     63       Copper or zinc 3; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        64     64       Copper or zinc 3; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        70     70       Copper or zinc 4.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        71     71       Copper or zinc 4; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        72     72       Copper or zinc 4; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   LIPID       215    215       GPI-anchor amidated serine.
FT                                {ECO:0000250|UniProtKB:P04273}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    182    182       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    164    199       {ECO:0000250|UniProtKB:P04273}.
FT   NON_TER       1      1
SQ   SEQUENCE   238 AA;  26123 MW;  5F59A3EBC3E3531B CRC64;
     MLVLFVATWS DLGLCKKRPK PGGWNTGGSR YPGQGSPGGN RYPPQGGGGW GQPHGGGWGQ
     PHGGGWGQPH GGGWGQGGGT HNQWHKPSKP KTSMKHMAGA AAAGAVVGGL GGYMLGSAMS
     RPLIHFGNDY EDRYYRENMY RYPNQVYYRP VDQYSNQNNF VHDCVNITIK QHTVTTTTKG
     ENFTETDVKM MERVVEQMCI TQYEKESQAY YQRGSSMVLF SSPPVILLIS FLIFLIVG
//
ID   PRIO_CRIMI              Reviewed;         254 AA.
AC   Q60468;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   08-MAY-2019, entry version 95.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: Full=PrP27-30;
DE   AltName: Full=PrP33-35C;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor;
GN   Name=PRNP; Synonyms=PRP;
OS   Cricetulus migratorius (Gray dwarf hamster).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Cricetidae; Cricetinae; Cricetulus.
OX   NCBI_TaxID=10032;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=2406562; DOI=10.1128/MCB.10.3.1153;
RA   Lowenstein D.H., Butler D.A., Westaway D., McKinley M.P.,
RA   DeArmond S.J., Prusiner S.B.;
RT   "Three hamster species with different scrapie incubation times and
RT   neuropathological features encode distinct prion proteins.";
RL   Mol. Cell. Biol. 10:1153-1163(1990).
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental
CC       stresses. May play a role in neuronal development and synaptic
CC       plasticity. May be required for neuronal myelin sheath
CC       maintenance. May play a role in iron uptake and iron homeostasis.
CC       Soluble oligomers are toxic to cultured neuroblastoma cells and
CC       induce apoptosis (in vitro). Association with GPC1 (via its
CC       heparan sulfate chains) targets PRNP to lipid rafts. Also provides
CC       Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
CC       degradation of its heparan sulfate side chains (By similarity).
CC       {ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent
CC       an intermediate stage on the path to fibril formation. Copper
CC       binding may promote oligomerization. Interacts with GRB2, APP,
CC       ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
CC       interacts with MGRN1; this interaction alters MGRN1 subcellular
CC       location and causes lysosomal enlargement. Interacts with
CC       KIAA1191. {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
CC       {ECO:0000250|UniProtKB:P04156}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
CC       association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear
CC       regions, where both proteins undergo internalization. Heparin
CC       displaces PRNP from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby
CC       trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
CC       At low copper concentrations, the sidechains of His residues from
CC       three or four repeats contribute to the binding of a single copper
CC       ion. Alternatively, a copper ion can be bound by interaction with
CC       the sidechain and backbone amide nitrogen of a single His residue.
CC       The observed copper binding stoichiometry suggests that two repeat
CC       regions cooperate to stabilize the binding of a single copper ion.
CC       At higher copper concentrations, each octamer can bind one copper
CC       ion by interactions with the His sidechain and Gly backbone atoms.
CC       A mixture of binding types may occur, especially in the case of
CC       octamer repeat expansion. Copper binding may stabilize the
CC       conformation of this region and may promote oligomerization.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=PrP is found in high quantity in the brain of humans
CC       and animals infected with the degenerative neurological diseases
CC       kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
CC       syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
CC       transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; M33959; AAA37014.1; -; Genomic_DNA.
DR   SMR; Q60468; -.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   3: Inferred from homology;
KW   Amyloid; Cell membrane; Copper; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; GPI-anchor; Lipoprotein; Membrane; Metal-binding;
KW   Prion; Repeat; Signal; Zinc.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    231       Major prion protein.
FT                                /FTId=PRO_0000025667.
FT   PROPEP      232    254       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000025668.
FT   REPEAT       51     59       1.
FT   REPEAT       60     67       2.
FT   REPEAT       68     75       3.
FT   REPEAT       76     83       4.
FT   REPEAT       84     91       5.
FT   REGION       23    231       Interaction with GRB2, ERI3 and SYN1.
FT                                {ECO:0000250|UniProtKB:P04925}.
FT   REGION       51     91       5 X 8 AA tandem repeats of P-H-G-G-G-W-G-
FT                                Q.
FT   REGION       90    231       PrP27-30 (protease resistant core).
FT   METAL        61     61       Copper or zinc 1.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        62     62       Copper or zinc 1; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        63     63       Copper or zinc 1; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        69     69       Copper or zinc 2.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        70     70       Copper or zinc 2; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        71     71       Copper or zinc 2; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        77     77       Copper or zinc 3.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        78     78       Copper or zinc 3; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        79     79       Copper or zinc 3; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        85     85       Copper or zinc 4.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        86     86       Copper or zinc 4; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   METAL        87     87       Copper or zinc 4; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P04156}.
FT   LIPID       231    231       GPI-anchor amidated serine.
FT                                {ECO:0000250|UniProtKB:P04273}.
FT   CARBOHYD    181    181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250}.
FT   CARBOHYD    197    197       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250}.
FT   DISULFID    179    214       {ECO:0000250|UniProtKB:P04273}.
SQ   SEQUENCE   254 AA;  27855 MW;  7B963FC6F77F9D0F CRC64;
     MANLSYWLLA LFVATWTDVG LCKKRPKPGG WNTGGSRYPG QGSPGGNRYP PQGGGTWGQP
     HGGGWGQPHG GGWGQPHGGG WGQPHGGGWG QGGGTHNQWN KPNKPKTSMK HMAGAAAAGA
     VVGGLGGYML GSAMSRPMLH FGNDWEDRYY RENMNRYPNQ VYYRPVDQYN NQNNFVHDCV
     NITIKQHTVT TTTKGENFTE TDVKMMERVV EQMCVTQYQK ESQAYYDGRR SSAVLFSSPP
     VILLISFLIF LIVG
//
